TrialBone marrow transplantation2012
Allo-SCT for AML and MDS with treosulfan compared with BU-based regimens: reduced toxicity vs reduced intensity.
A Shimoni et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
24 papers cite it
this paperpooled ittrialcites it